With shares of Corning (NYSE:GLW) trading around $19, is GLW an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:
T = Trends for a Stock’s MovementCorning produces and sells specialty glasses, ceramics, and related materials worldwide. It operates in five segments: Display Technologies, Telecommunications, Environmental Technologies, Specialty Materials, and Life Sciences. Corning has launched Corning Lotus Glass, an environmentally friendly display glass for organic LED and LCD displays that are used in portable devices such as smartphones, tablets, and notebook computers. Smart phones, tablets, notebook computers, and related materials are seeing explosive growth in developed and developing countries around the world.
An executive from Corning�took the stage at the Morgan Stanley Technology, Media, and Telecom Conference on Tuesday to say that the company�� Gorilla Glass is a better material to be used in consumer electronics than sapphire crystals. Rumors have been swirling that Apple (NASDAQ:AAPL) is planning to switch to sapphire for the display in the next iPhone, as the company has recently purchased a sapphire manufacturing plant in Arizona to make the scratch-resistant material.�Tony Tripeny, a senior vice president at Corning, spoke to analysts about the sapphire issue at the conference.
Top 10 Blue Chip Stocks To Invest In Right Now: Brown-Forman Corp (BF.B)
Brown-Forman Corporation, incorporated on October 19, 1933, primarily manufactures, bottles, imports, exports, markets, and sells a variety of alcoholic beverage brands. The Company�� principal brands are Jack Daniel�� Tennessee Whiskey, Jack Daniel�� Tennessee Whiskey, Pepe Lopez Tequilas, Jack Daniel�� Single Barrel, Woodford Reserve Bourbons, Jack Daniel�� Ready-to-Drinks, Canadian Mist Blended Canadian Whiskies, Jack Daniel�� Tennessee Honey, Chambord Liqueur, Jack Daniel�� Winter Jack Chambord Vodka, Gentleman Jack, Collingwood Canadian Whisky, Southern Comfort, Early Times Bourbon, Southern Comfort Ready-to-Drinks, Early Times flavored line extensions, Southern Comfort flavored line extensions, Early Times Kentucky Whisky, Finlandia Vodkas, Korbel California Champagnes, Finlandia Ready-to-Drinks, Little Black Dress Vodkas, Antiguo Tequila, Maximus Vodkas, el Jimador Tequilas, Old Forester Bourbon, el Jimador New Mix Ready-to-Drinks, Sonoma-Cutrer Wines, Herradura Tequilas, and Tuaca Liqueur.
The Company�� products are sold in more than 150 countries around the world. The Company�� international markets include Australia, the United Kingdom, Mexico, Germany, Poland, France, Russia, Japan, Turkey, Canada, Spain, Czech Republic, South Africa, Brazil and Italy.
The Company competes with Bacardi Limited, Beam Inc., Davide Campari-Milano S.p.A., Diageo plc, LVMH Moet Hennessy Louis Vuitton S.A., Pernod Ricard S.A., and Remy Cointreau S.A.
Advisors' Opinion:- [By Holly LaFon]
TR: Definitely. The most likely places that they��l probably pop up are counterparts to the same businesses that we already own because the economics are good for Richemont (XSWX:CFR). They sell precious jewelry and luxury goods and watches to aspirational consumers around the world. The same economics drive Swatch. I don�� own Swatch, in big measure. I own it for a handful of clients. But that�� kind of the natural sourcing ground for me. I don�� own Compari. I do own Pernod Ricard (PDRDF), Diageo (DEO), Brown Forman (BF.B). Compari�� a great company. They have different brands and strengths in different categories than the three companies that we already own. I could own Compari.
- [By John Udovich]
Whiskey has become increasingly cool and popular thanks to the whole cocktail movement, something that�� good for big whiskey stocks like Suntory Beverage & Food Limited (OTCMKTS: STBFY), Diageo plc (NYSE: DEO) and Brown-Forman Corporation (NYSE: BF.B) who�also produce a wide variety of�liquors and beverages. In fact,�a recent episode of the�Daily Ticker�cited these stats from a USA Today article:
- [By Marc Bastow]
Alcohol manufacturer and distributor Brown-Forman (BF.B) raised its quarterly dividend 13.7% to 29 cents per share, payable on Dec. 27 to shareholders of record as of Dec. 4.
BF.B Dividend Yield: 1.54% - [By Chuck Carnevale]
Brown ��Forman (BF.B)
In contrast to Oracle Corp., we discover that Brown-Forman with a significantly lower earnings growth rate is currently trading at one of its highest valuations ever. When you consider that this company trades at a PE ratio of 23.3 versus the S&P 500 at a PE ratio of 13.7 or against Oracle with a PE ratio of only 12.1, we can see a wide variation in stock valuations of individual stocks as compared to the S&P 500 index.
Top 5 Life Sciences Stocks To Invest In Right Now: Raptor Pharmaceutical Corp.(RPTP)
Raptor Pharmaceuticals Corp. operates as a biotechnology company in the United States. The company is dedicated to speeding the delivery of new treatment options to patients by working to improve existing therapeutics through the application of highly specialized drug targeting platforms and formulation expertise. Its clinical stage development products include DR Cysteamine, which is in phase IIb for the treatment of cystinosis; phase IIa for the non-alcoholic steatohepatitis; and phase II for the treatment of Huntington?s disease. Raptor?s clinical-stage products also include Convivia that is in Phase IIa stage for the potential management of acetaldehyde toxicity due to alcohol consumption; and Tezampanel and NGX 426, which completed phase I stage for the treatment of migraine and pain. Its preclinical product candidates comprise HepTide for the treatment of Hepatocellular Carcinoma and Hepatitis; WntTide for the treatment of breast cancer; NeuroTrans for the treatmen t of neurodegenerative diseases; and Tezampanel and NGX 426 for the treatment of Thrombosis and Spasticity Disorder. Raptor Pharmaceuticals Corp. is headquartered in Novato, California.
Advisors' Opinion:- [By Jake L'Ecuyer]
Raptor Pharmaceuticals (NASDAQ: RPTP) was down, falling 10.04 percent to $13.31 after the company reported Q4 results. Raptor Pharmaceutical posted a Q4 loss of $0.20 per share, versus the projected loss of $0.16 per share.
- [By Sean Williams]
Raptor Pharmaceuticals (NASDAQ: RPTP ) also gave shareholders something to cheer about when, on Tuesday, the company announced that the Food and Drug Administration had granted Procysbi, its nephropathic cystinosis drug, U.S. orphan drug status. Although FDA-approved drugs are protected by patent for a period of 20 years, the U.S. orphan drug status will keep biosimilar competition from competing against Raptor's Procysbi through April 30, 2020. In addition, on Friday Procysbi received a positive opinion from the European Medicine Agency's panel that the drug be recommended for approval in the EU. However, I'd caution calmer heads prevail here as the total market for the drug is only about 2,000 people worldwide and peak sales estimates in the U.S. are a mere $60 million.
- [By Sean Williams]
This week saw two new drugs approved by the FDA: Raptor Pharmaceuticals' (NASDAQ: RPTP ) Procysbi and Merck's (NYSE: MRK ) Liptruzet.
- [By Roberto Pedone]
One biotechnology player that's starting to trend within range of triggering a big breakout trade is Raptor Pharmaceuticals (RPTP), which has a pipeline that includes both candidates from its proprietary drug targeting platforms and in-licensed and acquired product candidates. This stock is in play with the bulls so far in 2013, with shares up sharply by 151%.
>>5 Hated Earnings Stocks You Should Love
If you take a look at the chart for Raptor Pharmaceuticals, you'll notice that stock has been uptrending strong for the last six months, with shares soaring higher from its low of $5.50 to its recent high of $15.29 a share. During that uptrend, shares of RPTP have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of RPTP within range of triggering a big breakout trade.
Traders should now look for long-biased trades in RPTP if it manages to break out above some near-term overhead resistance levels at $14.99 a share to its 52-week high at $15.29 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 844,332 shares. If that breakout triggers soon, then RPTP will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $18 to $20 a share, or even north of $20 a share.
Traders can look to buy RPTP off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $13.69 a share or at $13 a share. One can also buy RPTP off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Top 5 Life Sciences Stocks To Invest In Right Now: Huntington Ingalls Industries Inc. (HII)
Huntington Ingalls Industries, Inc. designs, builds, overhauls, and repairs ships primarily for the U.S. Navy and Coast Guard. It offers nuclear-powered ships, such as aircraft carriers and submarines; and non-nuclear ships, including surface combatants, expeditionary warfare/amphibious assault, coastal defense surface ships, and national security cutters, as well as engages in the refueling and overhaul, and inactivation of nuclear-powered ships. The company also operates as a full-service systems provider for the design, engineering, construction, and life cycle support of major programs for surface ships; and a provider of fleet support and maintenance services for the U.S. Navy. In addition, it provides a range of support services, including fabrication, construction, equipment, and technical services, as well as product sales to commercial nuclear power plants, fossil power plants, and other industrial facilities, as well as government customers. The company is based in Newport News, Virginia.
Advisors' Opinion:- [By Rich Smith]
Following up on a $65 million contract award to fund purchases of "long lead material" in early March, and a further $407.4 million awarded a couple of weeks later, the Department of Defense modified its contract with Huntington Ingalls (NYSE: HII ) yet again on Monday.
- [By Katie Spence]
The money is running dry
Defense spending is being slashed left and right, which means the Pentagon is making hard decisions when it comes to military needs. Currently, there are a number of programs that the Pentagon is unwilling to sacrifice, such as Lockheed Martin's (NYSE: LMT ) F-35 fighter, Huntington Ingalls Industries' (NYSE: HII ) CVN-78 aircraft carrier, and Northrop Grumman's (NYSE: NOC ) RQ-4 Global Hawk drones -- good news for these guys. Then, there are other programs that the Pentagon has deemed less critical. That includes Boeing's C-17 contract. - [By Roberto Pedone]
Huntington Ingalls Industries (HII) is engaged in building, overhauling and repairing ships, mainly for the U.S. Navy and the U.S. Coast Guard. This stock closed up 1% at $64.11 in Friday's trading session.
Friday's Volume: 297,000
Three-Month Average Volume: 211,441
Volume % Change: 50%From a technical perspective, HII trended modestly higher here right above some near-term support levels at $62.13 to $61.74 with above-average volume. This move also pushed shares of HII into breakout territory, since the stock took out and closed above its previous 52-week high at $63.99.
Traders should now look for long-biased trades in HII as long as it's trending above some key near-term support at $62.13 or above $61.74 and then once it sustains a move or close above Friday's high of $64.14 with volume that hits near or above 211,441 shares. If we get that move soon, then HII will set up to enter new 52-week -igh territory, which is bullish technical price action. Some possible upside targets off that move are $70 to $72.
- [By Louis Navellier]
Here are three under-the-radar “best of the best” stocks to buy that get a “Triple-A” from Portfolio Grader and should power your portfolio in 2014.
Huntington Ingalls (HII)Huntington Ingalls (HII) builds and repairs ships, primarily for the U.S. Navy and the Coast Guard. Ingalls builds the giant nuclear aircraft carriers, nuclear submarines, cutters and every type of warship in between. HII also offers refueling and overhaul services for nuclear vessels.
Top 5 Life Sciences Stocks To Invest In Right Now: Track Data Corp (TRAC)
Track Data Corporation is a financial services company that provides real-time financial market data, fundamental research, charting and analytical services to institutional and individual investors through telecommunication lines and the Internet. The Company also disseminates news and third-party database information from approximately 100 sources worldwide. The Company operates in three segments: professional market, which provides market data services and trading, including electronic communications network (ECN) services, to the institutional professional investment community; non-professional market, which includes Internet-based online trading and market data services to the non-professional individual investor community, and arbitrage trading. Its wholly owned subsidiary, Track Data Securities Corp. (TDSC) is a registered securities broker-dealer. Track Data provides an integrated Internet-based online trading and market data system, proTrack, for the professional institutional traders, and myTrack and myTrack Edge, for the individual trader. It operates Track ECN, an ECN that enables traders to display and match limit orders for stocks.
Professional Market
MarkeTrack provides domestic and international market information, updating quotelines, options and futures displays, real-time spreadsheets, tick-by-tick updating graphics, news services and third-party databases, user-defined screen layouts, access to back-office order and execution services. The solution allows users to calculate theoretical values of options and determine the most beneficial investment strategy through calculating returns on alternative investments, including options and futures. MarkeTrack serves approximately 700 customers in trading and institutional investment management positions. Customers include floor traders, block traders, market makers, over the counter (OTC) traders, options specialists, head traders, arbitrageurs and hedge fund managers.
The Company offers proTrack ! as a direct access trading system for the professional market. Among the trading features offered by proTrack are point and click equities and options trading, direct access to market makers and ECNs, hot keys, smart order routing, reserve book, quick modification of existing orders, multiple order types and a variety of market data and news. proTrack offers trading through TDSC and clearing through Penson Financial Services, Inc. It is also available for use by other broker dealers under a service bureau arrangement.
TDSC operates an ECN that enables traders to display and match limit orders for stocks. The ECN allows trading of National Association of Securities Dealers Automated Quotation (Nasdaq) Global Market, Nasdaq Capital Market, New York Stock Exchange (NYSE) and American Stock Exchange (AMEX) listed securities, and exchange-listed securities on its platform. Track ECN displays orders on the National Stock Exchange (NSX). Track Data Corporation's NewsWatch service includes a consolidated news ticker, including database with text indexing and access to a variety of third-party databases.
The Company competes with Bloomberg Financial, Thomson/Reuters Group, Goldman Sachs, Lehman Brothers, Inc., Lava, Inc., Acquire Media, NYSE, Nasdaq, DirectEdge and BATS.
Non-Professional Market
Track Data offers Internet-based online trading and market data services through its myTrack and myTrack Edge products. myTrack and myTrack Edge offer trading of United States-based stocks, options and mutual funds, as well as stock index-based futures. For those traders who are the most active and engage in day trading, the myTrack Pro contains multi windows-based features and enhancements that are designed to satisfy the needs of the trader community. myTrack Edge provides access to information on stocks, options, indices, and news, including bid and ask prices, charts, research and other information for any listed or Nasdaq-traded stock and numerous over-the-counte! r bulleti! n board (OTC-BB) stocks, as well as the ability to establish and track securities, cash, margin and buying power positions on a real-time basis. Real-time quotes, news, charting and technical analysis are available in various pay packages. Volume trading can result in rebates equivalent to the service plan charges.
The Company also offers AIQ Systems and Dial/Data Service. AIQ Systems develops and markets artificial intelligence (AI) based stock market analysis and charting software for personal computers. By simulating the reasoning of top market technicians, AIQ's Expert Systems delivers trading signals and market insight, as well as advanced technical charting and screening capabilities. Dial/Data is an Internet-based service that provides historical and end-of-day pricing data for United States, Canadian and European exchange-traded equities and related instruments, futures, equity options, futures options, mutual funds, bonds, government issues, money markets and indexes.
The Company competes with E*Trade Group, Inc., Trade Station Group, Inc., Charles Schwab & Co., Inc., Options Express, TD Ameritrade, Inc., e-Signal, DTN, AT Financial, Data Corp., The Dow Jones Retrieval Service, Compuserve, Telescan, Commodity Systems, Inc., Equis International, Windows on Wall Street and Omega.
Arbitrage Trading
The Company engages in arbitrage trading activity. Its trading strategy consists principally of establishing hedged positions consisting of stocks and options. The Company also engages in options trading. The Company's trading strategy consists of selling short deep out-of-the-money calls and puts.
Advisors' Opinion:- [By Bill Smith]
FDS operates in a highly competitive industry, some with more resources. Their competitors include:
Thomson Reuters Corp. (TRI)BloombergInteractive (IDC)MSCI Inc. (MXB)Morningstar Inc. (MORN)Track Data Corp. (TRAC)Edgar Online (EDGR)McGraw-Hill (MHP )
No comments:
Post a Comment